Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 901–1,000 of 1,000
García, M., García, A. C., Weigel, W., Christ, W., Lira‐Junior, R., Wirth, L. E., Tauriainen, J., Maleki, K. T., Vanoni, G., Vaheri, A. I., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012390 · Cited by 13
“IFN-γ is a cytokine with strong antiviral effects produced by a wide array of innate and adaptive lymphocytes, including ILCs, NK cells, NKT cells, and T cells [44,75–77].”
BackgroundSouza, R. D. O., Júnior, J. W. B. D., Casa, V. S. D., Rosa, D. S., Rénia, L., & Claser, C. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1421571 · Cited by 14
Evasion of the Antiviral Innate Immunity by PRV
Wang, C., Li, L., Zhai, X., Chang, H., & Liu, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313140 · Cited by 15
Ballana, E., & Esté, J. A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.017 · Cited by 12
Meade, E., Rowan, N. J., & Garvey, M. (2023) · Vaccines · doi:10.3390/vaccines11050992 · Cited by 13
“IFN-1 is particularly important in viral infection as it activates natural killer (NK) cells which can kill host infected cells and stimulate release of proinflammatory cytokines, including interleukins (ILs) [15].”
BackgroundInfluentialGrass carp Mre11A activates IFN 1 response by targeting STING to defend against GCRV infection
Xu, X., Li, M., Deng, Z., Li, D., Lu, S., Deng, H., Lv, Y., Liu, Y., Du, H., & Hu, C. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103909 · Cited by 11
Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus’ Lateral Body Protein
Giotis, E. S., Laidlaw, S. M., Bidgood, S. R., Albrecht, D., Burden, J. J., Robey, R. C., Mercer, J., & Skinner, M. A. (2020) · Biomedicines · doi:10.3390/biomedicines8120634 · Cited by 11
“Perhaps the best-studied antiviral host restriction mechanism is interferon (IFN)-mediated, against which almost all viruses have evolved defence mechanisms [7,8].”
BackgroundYu, L., Xu, Y., Wang, F., Yang, C., Liu, G., & Song, X. (2016) · BioMed Research International · doi:10.1155/2016/9872138 · Cited by 11
“In our study, poly(I:C) or HSV60 stimulation induced the upregulation of IFN-α and IFN-β, which are pleiotropic cytokines against viruses by inducing the expression of antiviral proteins [51, 52].”
BackgroundVaccinia Virus Recombinants as a Model System to Analyze Interferon-Induced Pathways
Gil, J., & Estéban, M. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990042475706 · Cited by 15
Characterization of alpha-enolase as an interferon-alpha 2 alpha 1 regulated gene
Lirlandia, P. S. (2005) · Frontiers in bioscience · doi:10.2741/1718 · Cited by 13
Virus Infection and the Interferon Response
Korth, M. J., Kash, J. C., Furlong, J. C., & Katze, M. G. (2005) · Humana Press eBooks · doi:10.1385/1-59259-939-7:037 · Cited by 11
Self-citationThe Anti-Interferon Mechanisms of Paramyxoviruses
Stock, N., Goodbourn, S., & Randall, R. E. (2006) · Springer eBooks · doi:10.1007/1-4020-3242-0_6 · Cited by 11
Nonpodocyte Roles of APOL1 Variants: An Evolving Paradigm
Pell, J. F., Nagata, S., & Menon, M. C. (2023) · Kidney360 · doi:10.34067/kid.0000000000000216 · Cited by 10
Characterization of High and Low IFNG-Expressing Subgroups in Atopic Dermatitis
Wasserer, S., Jargosch, M., Mayer, K. E., Eigemann, J., Raunegger, T., Aydin, G., Eyerich, S., Biedermann, T., Eyerich, K., & Lauffer, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116158 · Cited by 10
Rab8a restores diverse innate functions in CD11c+CD11b+ dendritic cells from aged mice
Singh, S., Tehseen, A., Dahiya, S., Singh, Y. J., Sarkar, R., & Sehrawat, S. (2024) · Nature Communications · doi:10.1038/s41467-024-54757-2 · Cited by 13
The role of aryl hydrocarbon receptor in antiviral immunity: a focus on RNA viruses
Grycová, A., Vyhlídalová, B., & Dvořák, Z. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2497789 · Cited by 11
“…AhR activation during viral infections can exacerbate pathogenesis by constraining the type-i and type-ii interferon response, activation of indolamine-2,3-dioxygenase 1 (iDO-1), and modulation of immune cells function (Katze et al. 2002; Barhoover et al. 2010; Schmidt and Schultze 2014).”
Usuda, J. N., Plaça, D. R., Fonseca, D. L. M., Marques, A. H. C., Filgueiras, I. S., Chaves, V. G. B., Adri, A. S., Torrentes‐Carvalho, A., Hirata, M. H., Freire, P. P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243516 · Cited by 10
Expression and purification of Canis interferon α in Escherichia coli using different tags
Yang, F., Pan, Y., Chen, Y., Tan, S., Jin, M., Wu, Z., & Huang, J. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.07.007 · Cited by 11
“Canonical type I IFNs activate the Janus kinase (JAK) signal transducer and activator of transcription (STAT) pathway, leading to the transcription of IFN-stimulated genes (ISGs), such as myxovirus-resistance protein, oligoadenylate synthetase, and protein kinase[8, 9].”
BackgroundMicroarray analysis reveals increased expression of ΔNp63α in seborrhoeic keratosis
Seo, E. Y., Lee, D. H., Lee, Y., Cho, K. H., Eun, H. C., & Chung, J. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10665.x · Cited by 10
Interferons as Biomarkers and Effectors: Lessons Learned from Animal Models
Berry, C., Hertzog, P. J., & Mangan, N. E. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.10 · Cited by 10
Kim, J., Cho, M., Kim, K. I., Min, E., Lim, J.-W., & Hong, S. (2021) · Archives of Virology · doi:10.1007/s00705-021-04980-9 · Cited by 10
Saxena, V., Bolling, B. G., & Wang, T. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.01.001 · Cited by 17
Boeren, M., Breedam, E. V., Buyle-Huybrecht, T., Lebrun, M., Meysman, P., Sadzot‐Delvaux, C., Tendeloo, V. F. V., Mortier, G. R., Laukens, K., Ogunjimi, B., et al. (2022) · Viruses · doi:10.3390/v14112517 · Cited by 10
The long‐term but not the short‐term antiviral effectof IFN‐α depends on Flt3 ligand and pDC
Vollstedt, S., O’Keeffe, M. A., Ryf, B., Glanzmann, B., Hochrein, H., & Suter, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200535759 · Cited by 10
p204‐mediated innate antiviral responses in mouse adipose cells and their effects on cell functions
Yu, L., Liu, P., Liu, Z., Zhu, W., Yan, K., Chen, Q., & Han, D. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.83 · Cited by 11
Viruses and autoimmune diseases—adapting Koch's postulates
Denman, A. M., & Rager‐Zisman, B. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.03.001 · Cited by 10
McFadden, G., & Nazarian, S. H. (2005) · Future Virology · doi:10.2217/17460794.1.1.123 · Cited by 10
“Type II interferon inhibition IFN-γ (type II IFN) is an integral component of both the innate and host adaptive immune system and susceptibility to virus infection can be modulated profoundly with this cytokine [22].”
BackgroundLiang, H., Zhang, H., Kang, X., Zhu, C. Y., Wang, L., & Zeng, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1282922 · Cited by 9
Vandoren, R., Boeren, M., Schippers, J., Bartholomeus, E., Mullan, K. A., Michels, N. R. M., Aerts, O., Leysen, J., Bervoets, A., Lambert, J. R., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad609 · Cited by 12
Xu, H. C., Pandey, P., Ward, H., Gorzkiewicz, M., Abromavičiūtė, D., Tinz, C., Müller, L., Meyer, C., Pandyra, A. A., Yavas, A., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300637 · Cited by 8
Nosik, M. N., Ryzhov, K., Kudryavtseva, А. V., Kuimova, U., Kravtchenko, A., Sobkin, A., Zverev, V. V., & Свитич, О. А. (2024) · Biomedicines · doi:10.3390/biomedicines12050954 · Cited by 11
Hepatocytes and the art of killing Plasmodium softly
Marques-da-Silva, C., Schmidt-Silva, C., & Kurup, S. P. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.04.004 · Cited by 8
Fenn, J. R., Madon, K. J., Conibear, E., Derelle, R., Nevin, S., Kundu, R., Hakki, S., Tregoning, J. S., Koycheva, A., Derqui, N., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105475 · Cited by 8
Yanai, H., & Taniguchi, T. (2026) · Immunity & Inflammation · doi:10.1007/s44466-025-00019-9 · Cited by 13
Ghavami, S., Shahrokh, S., Hossein‐Khannazer, N., Shpichka, A. I., Aghdaei, H. A., Timashev, P. S., & Vosough, M. (2020) · PubMed Central · doi:10.22074/cellj.2020.7603 · Cited by 11
“IBD; Inflammatory bowel disease, ARDS; Acute respiratory distress syndrome, and ACE2; Angiotensin-converting enzyme-2.”
BackgroundInfluentialNg, T. L., Olson, E. J., Yoo, T. Y., Weiss, H. S., Koide, Y., Koch, P. D., Rollins, N. J., Mach, P., Meisinger, T., Bricken, T., et al. (2022) · mSystems · doi:10.1128/msystems.01466-21 · Cited by 9
Bhide, K., Mochnáčová, E., Tkáčová, Z., Petroušková, P., Kulkarni, A. D., & Bhide, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-13043-1 · Cited by 11
Programmed Necrosis in Host Defense
Mocarski, E. S. (2023) · Current topics in microbiology and immunology · doi:10.1007/82_2023_264 · Cited by 12
Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses
Rezaei, R., Boulton, S., Ahmadi, M., Petryk, J., Silva, M. D., Zamani, N. K., Singaravelu, R., St-Laurent, G., Daniel, L., Sadeghipour, A., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01259-7 · Cited by 10
“…to rapidly usurp cellular protein synthesis, providing viruses with the ability to evade cellular innate antiviral responses, enhance the production of viral proteins, skew cellular resource allocation towards virus replication and, in some cases, delay cellular apoptosis programs 18,19 .”
Qin, X., Chen, G., Feng, Y., Zhu, X., Du, Y., Pang, W., Qi, Z., & Cao, Y. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.234.271 · Cited by 9
“contribute to B-cell activation and immunoglobulin production through the direct cell-to-cell contact with B cells as well as via pDC-derived soluble factors (Hemmi et al. 2000; Bauer et al. 2001; Kadowaki et al. 2001; Katze et al. 2002; Poeck et al. 2004).”
BackgroundTranscriptional response of human umbilical vein endothelial cell to H9N2 influenza virus infection
Wang, W., Mu, X., Zhao, L., Wang, J., Chu, Y., Feng, X., Feng, B., Wang, X., Zhang, J., & Qiao, J. (2015) · Virology · doi:10.1016/j.virol.2015.03.037 · Cited by 10
Afzal, S., Idrees, M., Ali, M., Ilyas, M., Hussain, A., Akram, M., Butt, S., Saleem, S., Rehman, I., Ali, L., et al. (2011) · Virology Journal · doi:10.1186/1743-422x-8-71 · Cited by 9
“Many viruses have developed mechanisms to dodge the IFNdependent cellular response [14].”
BackgroundGlances in Immunology of HIV and HCV Infection
Quaranta, M. G., Mattioli, B., & Vella, S. (2012) · Advances in Virology · doi:10.1155/2012/434036 · Cited by 9
Tackling HLA Deficiencies Head on with Oncolytic Viruses
Fisher, K. D., Hazini, A., & Seymour, L. W. (2021) · Cancers · doi:10.3390/cancers13040719 · Cited by 11
Srivastava, S., Chaudhary, N., Ojha, A., Guchhait, P., & Patel, A. K. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198436 · Cited by 9
Quantification of Type I Interferon Inhibition by Viral Proteins: Ebola Virus as a Case Study
Locke, M., Lythe, G., López‐García, M., Muñoz‐Fontela, C., Carroll, M. W., & Molina-París, C. (2021) · Viruses · doi:10.3390/v13122441 · Cited by 13
“632 h−1 per molecule [39] 1, 2, 3 kV U[−7, 2] h−1 per molecule pair [26,27] 1, 2, 3 qV U[−6, 2] h−1 per molecule [26,27] 1, 2, 3 kP U[−7,−2] h−1 per molecule pair 2, 3 qP U[−6, 0] h−1 per molecule 2, 3 kM U[−7,−2] h−1 per molecule pair 2, 3 qM U[−6, 0] h−1 per molecule 2, 3 kB U[−6, 8] h−1 per molecule [15,40] 1, 2 qB…”
BackgroundInfluentialSurgical Strikes on Host Defenses: Role of the Viral Protease Activity in Innate Immune Antagonism
Chin, C. V., & Saeed, M. (2022) · Pathogens · doi:10.3390/pathogens11050522 · Cited by 12
“Viruses, on the other hand, must circumvent host defenses to complete their lifecycle [8].”
BackgroundAkbar, S. M. F., Mahtab, M. A., Khan, S., Yoshida, O., & Hiasa, Y. (2022) · Vaccines · doi:10.3390/vaccines10101644 · Cited by 10
Reiss, C. S. (2009) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s6776 · Cited by 9
Neau, D., Galpérine, T., Legrand, E., Pitard, V., Neau‐Cransac, M., Moreau, J., Ragnaud, J., Dupon, M., Fleury, H. J., & Lafon, M. (2003) · HIV Medicine · doi:10.1046/j.1468-1293.2003.00140.x · Cited by 9
Heiber, J. F., Xu, X., & Barber, G. N. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10205 · Cited by 9
Cytosolic DNA sensor-initiated innate immune responses in mouse ovarian granulosa cells
Yan, K., Feng, D., Liang, J., Wang, Q., Deng, L., Zhang, X., Ling, B., & Han, D. (2017) · Reproduction · doi:10.1530/rep-16-0674 · Cited by 9
“IFNA and IFNB play crucial roles in the antiviral activities through the 448 upregulation of antiviral proteins and the promotion of adaptive immune responses against 449 invading viruses (Katze et al. 2002).”
BackgroundWang, W., & Ma, W. (2017) · Communications in Nonlinear Science and Numerical Simulation · doi:10.1016/j.cnsns.2017.11.024 · Cited by 9
Type I interferons: One stone to concurrently kill two birds, viral infections and cancers
Kumar, A., Khani, A. T., & Swaminathan, S. (2021) · Current Research in Virological Science · doi:10.1016/j.crviro.2021.100014 · Cited by 9
Seki, M., Hashiguchi, K., Kosai, K., Higashiyama, Y., Yanagihara, K., Kurihara, S., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Tashiro, T., et al. (2006) · Nagasaki University's Academic Output SITE (Nagasaki University) · doi:10.11343/amn.51.121 · Cited by 9
Berzsenyi, M. D., Roberts, S. K., & Beard, M. R. (2006) · Antiviral Therapy · doi:10.1177/135965350601100515 · Cited by 9
“ular virus have an important effect on the outcome [39].”
BackgroundTherapy of poxvirus infections
Snoeck, R., Andreï, G., & Clercq, E. D. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7557-7_18 · Cited by 9
“These viruses encode soluble versions of cytokine receptors that intercept the normal activities of the target cytokines, e.g., proteins that bind to and prevent IFN-_ /` and IFN-a from binding to their respective receptors on the cell membrane [84, 85 ].”
BackgroundHost Cell Targets in HCV Therapy: Novel Strategy or Proven Practice?
Klebl, B., Kurtenbach, A., Salassidis, K., Daub, H., & Herget, T. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600201 · Cited by 9
“In particular, specific genes and proteins have been found to be consistently up- or down-regulated after infection with HCV (Bigger et al., 2001; Su et al., 2002; Katze et al., 2002).”
BackgroundInfluentialWalczak, H., Koschny, R., Willen, D., Schader, M. B., Sykora, J., Ganten, T. M., & Haas, T. L. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch2 · Cited by 10
Kim, S., Choi, H. N., Jo, M. G., Lee, B., Kim, Y. J., Seong, H., Song, C., Yoo, H. S., Lee, J. H., Seong, D.-S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29854 · Cited by 8
“36 These mice are commonly used as an immunocompromised model to study the mechanisms of viruses because of their high susceptibility to viral infection.”
cGAS‐STING Pathway's Impact on Intestinal Barrier
Li, L., He, Y., Chen, Y., & Zhou, X. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16974 · Cited by 8
Self-citationBoceprevir and personalized medicine in hepatitis C virus infection
Habersetzer, F., Leboeuf, Doffoël, & Baumert, T. F. (2012) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s24259 · Cited by 8
“IFN-α does not act directly on HCV itself but exerts its antiviral activity through a cell membrane receptor, thereby activating IFN-stimulating genes that in turn will have intracellular antiviral effects.(12) It is unclear whether IFN-α, through its immunomodulatory properties, accelerates the clearance of infected…”
BackgroundLiu, L., Deng, C., Duan, Y., Ye, C.-J., Gong, D., Guo, X., Lee, W., Zhou, J., Li, S., & Zhang, Y. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001056 · Cited by 7
Urban living can rescue Darwin's finches from the lethal effects of invasive vampire flies
Knutie, S. A., Webster, C., Vaziri, G. J., Albert, L., Harvey, J. A., Larue, M. A., Verrett, T. B., Soldo, A., Koop, J. A. H., Chaves, J. A., et al. (2024) · Global Change Biology · doi:10.1111/gcb.17145 · Cited by 12
“Most studies suggest that IFNs are largely involved in resistance to viruses (Fensterl & Sen, 2009; Katze et al., 2002 ).”
BackgroundTherapeutic potential of oncolytic viruses in the era of precision oncology.
Kingsak, M., Meethong, T., Jongkhumkrong, J., Li, C., & Wang, Q. (2023) · PubMed Central · doi:10.12336/biomatertransl.2023.02.003 · Cited by 12
Roesmann, F., Sertznig, H., Klaassen, K., Wilhelm, A., Heininger, D., Heß, S., Elsner, C., Marschalek, R., Santiago, M. L., Eßer, S., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00534-24 · Cited by 9
“They are essential components of the innate immune response, being rapidly induced upon viral recognition (34, 35).”
BackgroundHCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
Wang, Y., Li, J., Wang, X., Zhou, Y., Zhang, T., & Ho, W. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.29282 · Cited by 9
“The action of IFN on virus-infected cells is to elicit an antiviral state, which is characterized by induction of IFN-stimulated genes (ISGs) (23).”
BackgroundIRF family transcription factors in type I interferon induction
Yanai, H., Mizutani, T., Inuzuka, T., Honda, K., Takaoka, A., & Taniguchi, T. (2005) · International Congress Series · doi:10.1016/j.ics.2005.09.010 · Cited by 8
Herath, T. K., Thompson, K. D., Adams, A., & Richards, R. H. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.05.011 · Cited by 8
Han, Y. W., Singh, S. K., & Eo, S. K. (2012) · Immune Network · doi:10.4110/in.2012.12.2.48 · Cited by 8
Evolution of the Humoral Response during HCV Infection
Murira, A., Lapierre, P., & Lamarre, A. (2015) · Advances in immunology · doi:10.1016/bs.ai.2015.09.004 · Cited by 9
Interaction of virus populations with their hosts
Domingo, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816331-3.00004-0 · Cited by 10
Bakács, T., Sandig, V., & Kovesdi, I. (2023) · Pharmaceuticals · doi:10.3390/ph16020226 · Cited by 8
“In such a way, they are able to minimize the antiviral power of IFNs [14].”
BackgroundCell-type-specific need of Ddx3 and PACT for interferon induction by RNA viruses
Sharma, N., Kessler, P., & Sen, G. C. (2023) · Journal of Virology · doi:10.1128/jvi.01304-23 · Cited by 11
Wu, W., Arunagiri, V., Do-Umehara, H. C., Chen, C., Gu, S., Biswas, I., Ridge, K. M., Budinger, G. R. S., Liu, S., & Liu, J. (2024) · Science Signaling · doi:10.1126/scisignal.adg7867 · Cited by 9
“On the other hand, influenza viruses have developed multiple strategies to circumvent the first line of defense embodied by the IFN system to replicate efficiently and successfully establish an infection ( 23 , 24 ).”
BackgroundJAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia
Young, A. P., & Denovan‐Wright, E. M. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10115-z · Cited by 7
“Elevated systemic IFNγ is associated with several conditions, including viral infection, alcohol abuse, obesity, and aging (Bandrés et al. 2000; Katze et al. 2002; Pacifico et al. 2006; Lowe et al. 2020).”
Vermeulen, B. L., Gleich, S. E., Dedeurwaerder, A., Olyslaegers, D. A. J., Desmarets, L. M. B., Dewerchin, H. L., & Nauwynck, H. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.03.004 · Cited by 8
Xu, D., Zhang, Y., Zhao, L., Cao, M., Lingel, A., & Zhang, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.005 · Cited by 8
Ghazawi, I., Cutler, S. J., Low, P., Mellick, A. S., & Ralph, S. J. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.92 · Cited by 10
Modeling the Interaction of Interferon α-1b to Bovine Serum Albumin as a Drug Delivery System
Luo, Q., Wang, Y., Hongge, Y., Liu, C., Ding, Y., Xu, H. C., Wang, Q., Liu, Y., & Xie, Y. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp5041713 · Cited by 8
Romani, S., Hosseini, S. M., Mohebbi, S. R., Boonstra, A., & Sharifian, A. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12699 · Cited by 8
Mubarak, A., Alrfaei, B. M., AlJurayyan, A. N., Alqafil, M. M., Farrag, M. A., Hamed, M. E., Alosaimi, B., Almajhdi, F. N., & Alturaiki, W. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s312337 · Cited by 8
Designer siRNAs to overcome the challenges from the RNAi pathway.
Jayasena, S. D. (2005) · PubMed Central · Cited by 8
Meiring, H. D., Soethout, E. C., de Jong, A. P. J. M., & van Els, C. A. C. M. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1603s77 · Cited by 8
“…based on the detergent lysis of antigen presenting cells, followed by acid elution of the bound peptides from their MHC molecules (Demotz et al., 1989; Rotzschke et al., 1990; van Bleek and Nathenson, 1990; Wallny and Rammensee, 1990; Falk et al., 1991; Huczko et al., 1993; Kubo et al., 1994).”
BackgroundAchour, A., Mbika, J., & Biquard, J. M. (2009) · Virology · doi:10.1016/j.virol.2008.12.041 · Cited by 9
Oh, B., Park, S., Yang, M., Yang, D., Ham, G., Tark, D., You, M., Oh, S., & Kim, B. (2024) · Viruses · doi:10.3390/v16030401 · Cited by 7
“The antiviral state induced by interferon activity in virus-infected cells and tissues is mediated through the generation of interferon-stimulated Viruses 2024 , 16 , 401 2 of 15 genes [12].”
BackgroundEndogenous and exogenous cytokines: An overview and introduction
Spitzer, T. R., & Lazarus, H. M. (2025) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2025.101615 · Cited by 8
Mueller, N., Dujsikova, A., Singh, A. K., & Chen, Y. G. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf031 · Cited by 8
HYVÄRINEN, A., Yongabi, F. N., Mäkinen, K., Wahlfors, J., & Pellinen, R. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1395 · Cited by 7
“In surrounding cells, they trigger a signaling cascade leading to expression of IFN-inducible genes (26).”
Immunology of hepatitis D virus infection: General concepts and present evidence
Hoblos, R., & Kefalakes, H. (2022) · Liver International · doi:10.1111/liv.15424 · Cited by 7
Pan, F., Ma, X., Tang, X., Xing, J., Sheng, X., Chi, H., & Zhan, W. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.108493 · Cited by 7
Non‐cytopathic bovine viral diarrhoea virus 2 induces autophagy to enhance its replication
Shin, S.-U., Han, D., Cho, H.-C., Kim, E., & Choi, K. (2022) · Veterinary Medicine and Science · doi:10.1002/vms3.1052 · Cited by 8
“Suppression of PKR activation is critical for efficient replication of many viruses, delaying apoptosis and facilitating the establishment of persistent infection (Katze et al., 2002; Leib et al., 2000).”
BackgroundPlaça, D. R., Fonseca, D. L. M., Marques, A. H. C., Pour, S. Z., Usuda, J. N., Baiocchi, G. C., Prado, C. A. D. S., Salgado, R. C., Filgueiras, I. S., Freire, P. P., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1282754 · Cited by 7
Acidic pH of early endosomes governs SARS-CoV-2 transport in host cells
Fares, P., Duhaini, M., Tripathy, S. K., Srour, A., & Kondapalli, K. C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108144 · Cited by 7
Innate Immune Sensing of Parapoxvirus Orf Virus and Viral Immune Evasion
AlDaif, B. A., & Fleming, S. B. (2025) · Viruses · doi:10.3390/v17040587 · Cited by 11
“As described above, IFNs induce hundreds of antiviral effectors [56,141,142], and poxviruses in particular encode factors that interfere with their actions [127,143].”
Zhang, X., Daucher, M., Baeza, J., Kim, C., Russell, R., & Kottilil, S. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23315 · Cited by 7
“…have acquired through evolution numerous anti-IFN strategies to evade early host immune responses, and counteract the IFN system by abolishing the activities of key factors of virus-induced signaling and IFN-a/b gene expression [Levy and Garcia-Sastre, 2001; Katze et al., 2002; Saito et al., 2008].”
BackgroundProtein Degradation by Gammaherpesvirus RTAs: More Than Just Viral Transactivators
Combs, L. R., Combs, J. E., McKENNA, R. V., & Tóth, Z. (2023) · Viruses · doi:10.3390/v15030730 · Cited by 8
“Interferon regulatory factors (IRFs), more specifically, IRF1, IRF3, IRF5, and IRF7, are important for the induction of IFNs and Interferon-stimulated genes (ISGs) during viral infection [68,69].”
BackgroundDurnell, L. A., Hippee, C. E., Cattaneo, R., Bartlett, J. A., Singh, B. K., & Sinn, P. L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01361-23 · Cited by 7
“In many viral infections, an effective innate antiviral response includes interferon (IFN) induction by pattern recognition receptors (24, 25).”
BackgroundHIV ‐1 replication requires optimal activation of the unfolded protein response
Tripathi, A., Iyer, K., & Mitra, D. (2023) · FEBS Letters · doi:10.1002/1873-3468.14772 · Cited by 9
“Viral infection may trigger the development of the interferon (IFN)- dependent antiviral innate immune response, which is the first line of defense against HIV infection [64,65].”
BackgroundInfection Profiles of Selected Aquabirnavirus Isolates in CHSE Cells
Gamil, A. A. A., Evensen, Ø., & Mutoloki, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134173 · Cited by 8
“While some viruses disrupt Type I IFN induction, others antagonize the responses by disrupting the signaling cascade or, more specifically, target downstream genes and their products [43,44].”
Background
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.